133 related articles for article (PubMed ID: 1840290)
1. Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.
Vitols S
Cancer Cells; 1991 Dec; 3(12):488-95. PubMed ID: 1840290
[TBL] [Abstract][Full Text] [Related]
2. [Targeting of tumor cells by low density lipoproteins: principle and use of ellipticin derivatives].
Favre G
C R Seances Soc Biol Fil; 1992; 186(1-2):73-87. PubMed ID: 1450992
[TBL] [Abstract][Full Text] [Related]
3. Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway.
Lundberg B
Cancer Res; 1987 Aug; 47(15):4105-8. PubMed ID: 3607752
[TBL] [Abstract][Full Text] [Related]
4. Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells.
Koller-Lucae SK; Schott H; Schwendener RA
Br J Cancer; 1999 Jul; 80(10):1542-9. PubMed ID: 10408395
[TBL] [Abstract][Full Text] [Related]
5. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
[TBL] [Abstract][Full Text] [Related]
6. Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo.
Versluis AJ; Rump ET; Rensen PC; van Berkel TJ; Bijsterbosch MK
J Pharmacol Exp Ther; 1999 Apr; 289(1):1-7. PubMed ID: 10086980
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents.
Glickson JD; Lund-Katz S; Zhou R; Choi H; Chen IW; Li H; Corbin I; Popov AV; Cao W; Song L; Qi C; Marotta D; Nelson DS; Chen J; Chance B; Zheng G
Mol Imaging; 2008; 7(2):101-10. PubMed ID: 18706292
[TBL] [Abstract][Full Text] [Related]
8. Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake.
Chung NS; Wasan KM
Adv Drug Deliv Rev; 2004 May; 56(9):1315-34. PubMed ID: 15109771
[TBL] [Abstract][Full Text] [Related]
9. MR and fluorescent imaging of low-density lipoprotein receptors.
Li H; Gray BD; Corbin I; Lebherz C; Choi H; Lund-Katz S; Wilson JM; Glickson JD; Zhou R
Acad Radiol; 2004 Nov; 11(11):1251-9. PubMed ID: 15561572
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice.
Masquelier M; Vitols S; Peterson C
Cancer Res; 1986 Aug; 46(8):3842-7. PubMed ID: 3731059
[TBL] [Abstract][Full Text] [Related]
11. Prolonged serum half-life of antineoplastic drugs by incorporation into the low density lipoprotein.
de Smidt PC; van Berkel TJ
Cancer Res; 1990 Dec; 50(23):7476-82. PubMed ID: 2147578
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells.
Lestavel-Delattre S; Martin-Nizard F; Clavey V; Testard P; Favre G; Doualin G; Houssaini HS; Bard JM; Duriez P; Delbart C
Cancer Res; 1992 Jul; 52(13):3629-35. PubMed ID: 1617635
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effect of a lipophilic alkylating agent after incorporation into low density lipoprotein or emulsions: studies in human leukemic cells.
Masquelier M; Lundberg B; Peterson C; Vitols S
Leuk Res; 2006 Feb; 30(2):136-44. PubMed ID: 16085310
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ
Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533
[TBL] [Abstract][Full Text] [Related]
15. Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.
Bijsterbosch MK; Ziere GJ; Van Berkel TJ
Mol Pharmacol; 1989 Sep; 36(3):484-9. PubMed ID: 2550781
[TBL] [Abstract][Full Text] [Related]
16. Visualization of binding and receptor-mediated uptake of low density lipoproteins by human endothelial cells.
Mommaas-Kienhuis AM; Krijbolder LH; Van Hinsbergh VW; Daems WT; Vermeer BJ
Eur J Cell Biol; 1985 Mar; 36(2):201-8. PubMed ID: 3996431
[TBL] [Abstract][Full Text] [Related]
17. High level of low-density lipoprotein receptors enhance hypericin uptake by U-87 MG cells in the presence of LDL.
Kascakova S; Nadova Z; Mateasik A; Mikes J; Huntosova V; Refregiers M; Sureau F; Maurizot JC; Miskovsky P; Jancura D
Photochem Photobiol; 2008; 84(1):120-7. PubMed ID: 18173711
[TBL] [Abstract][Full Text] [Related]
18. Low density lipoprotein as a carrier of cytostatics in cancer chemotherapy: study of stability of drug-carrier complexes in blood.
Masquelier M; Vitols S; Pålsson M; Mårs U; Larsson BS; Peterson CO
J Drug Target; 2000; 8(3):155-64. PubMed ID: 10938525
[TBL] [Abstract][Full Text] [Related]
19. Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy.
Vitols S; Angelin B; Ericsson S; Gahrton G; Juliusson G; Masquelier M; Paul C; Peterson C; Rudling M; Söderberg-Reid K
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2598-602. PubMed ID: 2320578
[TBL] [Abstract][Full Text] [Related]
20. Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo.
Vitols S; Peterson C; Larsson O; Holm P; Aberg B
Cancer Res; 1992 Nov; 52(22):6244-7. PubMed ID: 1423268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]